Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
[Experimental autoimmune uveitis. Characterization of retina infiltrating cells]
Ophthalmologe. 1999 Apr;96(4):252-6. Unique Identifier : AIDSLINE MED/99338008 Zierhut M; Wild U; Roser R; Wiggert B; Thiel HJ; Stiemer R; Abteilung I, Augenklinik der Universitat, Tubingen.
Abstract:
The chronic model of murine EAU induced by interphotoreceptor retinoid binding protein represents a disease similar to clinical chorioretinitis. In this study we characterized the kinetics of retina infiltrating T-cells, macrophages and expression of the adhesion molecules ICAM-1 and ICAM-2. METHODS: B10.A mice were immunized subcutaneously with IRBP, and the eyes were analyzed on days 10, 18, 24 and 28. The infiltrating cells were characterized by mAbs recognizing T-cell receptors (TCR) Vss6 and Vss8, T-cell markers, macrophages and ICAM-1 and ICAM-2. RESULTS: While CD8+ T-cells and ICAM-2 were detectable from day 10 (retina is intact) until day 28, CD4+ T-cells, macrophages and ICAM-1 appear with the onset of retinal destruction. Starting at day 10 the dominating TCR was Vss6; Vss8 was noticed from day 18 on. CONCLUSION: CD8+ T-cells infiltrating the intact retina and stimulating the expression of high endothelial venules (HEVs) could be responsible for the onset of uveitis.
Keywords: JOURNAL ARTICLE Retina infiltrierenden Zellen. Acute Disease Animal Antigens, CD/ANALYSIS Autoimmune Diseases/*IMMUNOLOGY Cell Adhesion Molecules/ANALYSIS Chorioretinitis/*IMMUNOLOGY CD8-Positive T-Lymphocytes/IMMUNOLOGY English Abstract Female Intercellular Adhesion Molecule-1/ANALYSIS Macrophages/*IMMUNOLOGY Mice Retina/IMMUNOLOGY Retinol-Binding Proteins/IMMUNOLOGY T-Lymphocytes/*IMMUNOLOGY Uveitis/*IMMUNOLOGY 991130
A99B1058
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.